Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 118 articles:
HTML format
Text format



Single Articles


    June 2017
  1. YANG C, Gomez A, Haldipur A, Berquist W, et al
    Growing Concerns: A 3-Year-Old Girl with Multiple Hepatic Masses and Gastrointestinal Bleeding.
    Dig Dis Sci. 2017 Jun 23. doi: 10.1007/s10620-017-4644.
    PubMed     Text format    


  2. FITTIPALDI S, Vasuri F, Bonora S, Degiovanni A, et al
    miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
    Dig Dis Sci. 2017 Jun 21. doi: 10.1007/s10620-017-4654.
    PubMed     Text format     Abstract available


    May 2017
  3. PANTHAM G, Post A, Venkat D, Einstadter D, et al
    A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.
    Dig Dis Sci. 2017 May 30. doi: 10.1007/s10620-017-4630.
    PubMed     Text format     Abstract available


  4. WALLACE MC, Huang Y, Preen DB, Garas G, et al
    HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4622.
    PubMed     Text format     Abstract available


  5. DE MATTEIS S, Granato AM, Napolitano R, Molinari C, et al
    Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 19. doi: 10.1007/s10620-017-4615.
    PubMed     Text format     Abstract available


  6. ROGAL SS, McCarthy R, Reid A, Rodriguez KL, et al
    Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4608.
    PubMed     Text format     Abstract available


  7. TAVAKOLI H, Robinson A, Liu B, Bhuket T, et al
    Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 4. doi: 10.1007/s10620-017-4595.
    PubMed     Text format     Abstract available


  8. DOYCHEVA I, Watt KD, Rifai G, Abou Mrad R, et al
    Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.
    Dig Dis Sci. 2017;62:1373-1380.
    PubMed     Text format     Abstract available


    April 2017
  9. HAMARNEH SR, Kim BM, Kaliannan K, Morrison SA, et al
    Intestinal Alkaline Phosphatase Attenuates Alcohol-Induced Hepatosteatosis in Mice.
    Dig Dis Sci. 2017 Apr 19. doi: 10.1007/s10620-017-4576.
    PubMed     Text format     Abstract available


  10. YOSHIDA T, Akiba J, Matsui T, Nakamura K, et al
    Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4550.
    PubMed     Text format     Abstract available


    March 2017
  11. CARR RM, Patel A, Bownik H, Oranu A, et al
    Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4495.
    PubMed     Text format     Abstract available


  12. KOHLI DR, Vachhani R, Shah TU, BouHaidar DS, et al
    Diagnostic Accuracy of Laboratory Tests and Diagnostic Imaging in Detecting Biliary Strictures After Liver Transplantation.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4515.
    PubMed     Text format     Abstract available


  13. PATIDAR KR, Thacker LR, Wade JB, White MB, et al
    Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis.
    Dig Dis Sci. 2017 Mar 3. doi: 10.1007/s10620-017-4509.
    PubMed     Text format     Abstract available


  14. KALAFATELI M, Zisimopoulos K, Vourli G, Rigamonti C, et al
    Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.
    Dig Dis Sci. 2017 Mar 1. doi: 10.1007/s10620-017-4504.
    PubMed     Text format     Abstract available


    February 2017
  15. CAI CX, Buddha H, Castelino-Prabhu S, Zhang Z, et al
    Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2017 Feb 13. doi: 10.1007/s10620-017-4470.
    PubMed     Text format     Abstract available


  16. KIM G, Huh JH, Lee KJ, Kim MY, et al
    Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2017 Feb 7. doi: 10.1007/s10620-017-4471.
    PubMed     Text format     Abstract available


    January 2017
  17. HUNG TH, Tseng CW, Tsai CC, Hsieh YH, et al
    Mortality Following Catheter Drainage Versus Thoracentesis in Cirrhotic Patients with Pleural Effusion.
    Dig Dis Sci. 2017 Jan 27. doi: 10.1007/s10620-017-4463.
    PubMed     Text format     Abstract available


  18. RIVEIRO-BARCIELA M, Tabernero D, Calleja JL, Lens S, et al
    Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Jan 11. doi: 10.1007/s10620-017-4448.
    PubMed     Text format     Abstract available


  19. YAN X, Shao C, Chen C, Chen J, et al
    Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing.
    Dig Dis Sci. 2017 Jan 5. doi: 10.1007/s10620-016-4408.
    PubMed     Text format     Abstract available


  20. KIM SK, Belikoff BG, Guevara CJ, Park SJ, et al
    An Algorithm for Management After Transjugular Intrahepatic Portosystemic Shunt Placement According to Clinical Manifestations.
    Dig Dis Sci. 2017 Jan 5. doi: 10.1007/s10620-016-4399.
    PubMed     Text format     Abstract available


  21. HU X, Feng Y, Sun L, Qu L, et al
    Roles of microRNA-330 and Its Target Gene ING4 in the Development of Aggressive Phenotype in Hepatocellular Carcinoma Cells.
    Dig Dis Sci. 2017 Jan 3. doi: 10.1007/s10620-016-4429.
    PubMed     Text format     Abstract available


    December 2016
  22. NARDELLI S, Allampati S, Riggio O, Mullen KD, et al
    Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.
    Dig Dis Sci. 2016 Dec 30. doi: 10.1007/s10620-016-4425.
    PubMed     Text format     Abstract available


  23. KIM EJ, Yeon JE, Kwon OS, Lee HN, et al
    Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4431.
    PubMed     Text format     Abstract available


  24. GOOSSENS N, Breguet R, De Vito C, Terraz S, et al
    Peribiliary Gland Dilatation in Cirrhosis: Relationship with Liver Failure and Stem Cell/Proliferation Markers.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4421.
    PubMed     Text format     Abstract available


  25. ANDREWS R, Queen T, Alcorn J, McCarthy D, et al
    A Remembrance of Procedures Past: Late Hepatic Artery Thrombosis.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  26. LI C, Wu M, Zong G, Wan C, et al
    Overexpression of Protein Phosphatase 1gamma (PP1gamma) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  27. ISHIOKA M, Miura K, Minami S, Shimura Y, et al
    Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    November 2016
  28. KAPLAN DE
    Prediction of Mortality in Chronic Liver Disease Using Non-hepatic Comorbidities: No SI of Relief as Yet.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  29. HWANG GL, Sze DY
    Survival in Cirrhotic Patients with High MELD Scores: The TIPping Point.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  30. WALLING AM, Ahluwalia SC, Wenger NS, Booth M, et al
    Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    October 2016
  31. TSOU YK, Liu CY, Fu KI, Lin CH, et al
    Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasms Is Feasible and Not Riskier for Patients with Liver Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  32. HEIDEMANN LA, Navarro VJ, Ahmad J, Hayashi PH, et al
    Erratum to: Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  33. QIU X, Wang X, Song Y, Chen L, et al
    Plasma Level of Interleukin-35 as an Independent Prognostic Indicator in Hepatocellular Carcinoma.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    September 2016
  34. WONG RJ
    Incorporating Clinical Research into a Career in Gastroenterology and Hepatology.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  35. ALLEGRETTI AS, Ortiz G, Kalim S, Wibecan J, et al
    Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  36. DONG T, Aronsohn A, Gautham Reddy K, Te HS, et al
    Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  37. NATARAJAN Y, White DL, El-Serag HB, Ramsey D, et al
    Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    August 2016
  38. HOEFS JC
    Prevention of the Paracentesis-Induced Circulatory Dysfunction (PICD) in Cirrhosis: Is the SPA Treatment Worthwhile?
    Dig Dis Sci. 2016.
    PubMed     Text format    


  39. LIU TL, Trogdon J, Weinberger M, Fried B, et al
    Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    July 2016
  40. HOU F, Qi X, Guo X
    Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  41. MONTANO-LOZA AJ, Thandassery RB, Czaja AJ
    Targeting Hepatic Fibrosis in Autoimmune Hepatitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  42. KIM JH, Sinn DH, Kim K, Kang W, et al
    Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  43. CHOUDHARY A, Barakat MT, Higgins LJ, Banerjee S, et al
    Choledochoscopic Identification of a Hepatic/Cystic Artery Pseudoaneurysm in a Patient with Hematemesis After Laparoscopic Cholecystectomy.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  44. KAPLAN DE, Dai F, Skanderson M, Aytaman A, et al
    Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    June 2016
  45. KUEI A, Lee EW, Saab S, Busuttil RW, et al
    Inpatient Cost Assessment of Transjugular Intrahepatic Portosystemic Shunt in the USA from 2001 to 2012.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  46. SCLAIR SN, Carrasquillo O, Czul F, Trivella JP, et al
    Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  47. CAMUS M, Khungar V, Jensen DM, Ohning GV, et al
    Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  48. THOMAS E, Schiff ER
    Early Detection of Steatohepatitis: Less Teeth NASHing and More Research?
    Dig Dis Sci. 2016.
    PubMed     Text format    


    May 2016
  49. LIU J, Ni W, Qu L, Cui X, et al
    Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  50. FAN X, Liu K, Che Y, Wang S, et al
    Good Clinical Outcomes in Budd-Chiari Syndrome with Hepatic Vein Occlusion.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  51. ASCHA M, Hanouneh M, S Ascha M, Zein NN, et al
    Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease >/=15.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  52. HEIDEMANN LA, Navarro VJ, Ahmad J, Hayashi PH, et al
    Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  53. FUCHS M, Schnabl B
    Editors' Introduction to the NAFLD and NASH Special Issue.
    Dig Dis Sci. 2016;61:1211-3.
    PubMed     Text format    


  54. HANNAH WN JR, Harrison SA
    Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016;61:1365-74.
    PubMed     Text format     Abstract available


  55. AFRICA JA, Newton KP, Schwimmer JB
    Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children.
    Dig Dis Sci. 2016;61:1375-86.
    PubMed     Text format     Abstract available


  56. SHERIF ZA, Saeed A, Ghavimi S, Nouraie SM, et al
    Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations.
    Dig Dis Sci. 2016;61:1214-25.
    PubMed     Text format     Abstract available


  57. KASWALA DH, Lai M, Afdhal NH
    Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
    Dig Dis Sci. 2016;61:1356-64.
    PubMed     Text format     Abstract available


  58. RATZIU V
    Novel Pharmacotherapy Options for NASH.
    Dig Dis Sci. 2016;61:1398-405.
    PubMed     Text format     Abstract available


  59. GOH GB, McCullough AJ
    Natural History of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016;61:1226-33.
    PubMed     Text format     Abstract available


  60. ABDOU RM, Zhu L, Baker RD, Baker SS, et al
    Gut Microbiota of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016;61:1268-81.
    PubMed     Text format     Abstract available


  61. BEDOSSA P
    Histological Assessment of NAFLD.
    Dig Dis Sci. 2016;61:1348-55.
    PubMed     Text format     Abstract available


  62. KINNER S, Reeder SB, Yokoo T
    Quantitative Imaging Biomarkers of NAFLD.
    Dig Dis Sci. 2016;61:1337-47.
    PubMed     Text format     Abstract available


  63. ARRESE M, Cabrera D, Kalergis AM, Feldstein AE, et al
    Innate Immunity and Inflammation in NAFLD/NASH.
    Dig Dis Sci. 2016;61:1294-303.
    PubMed     Text format     Abstract available


  64. MANTOVANI A, Ballestri S, Lonardo A, Targher G, et al
    Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016;61:1246-67.
    PubMed     Text format     Abstract available


  65. SZABO G, Csak T
    Role of MicroRNAs in NAFLD/NASH.
    Dig Dis Sci. 2016;61:1314-24.
    PubMed     Text format     Abstract available


  66. CZAJA MJ
    Function of Autophagy in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016;61:1304-13.
    PubMed     Text format     Abstract available


    April 2016
  67. LIN XJ, Lao XM, Shi M, Li SP, et al
    Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  68. ZONG G, Xu Z, Zhang S, Shen Y, et al
    CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  69. MENDEL I, Yacov N, Shoham A, Ishai E, et al
    Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  70. CHO Y, Cho EJ, Lee JH, Yu SJ, et al
    Hypoxia Enhances Tumor-Stroma Crosstalk that Drives the Progression of Hepatocellular Carcinoma.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  71. COZEN ML, Ryan JC, Shen H, Cheung R, et al
    Improved Survival Among all Interferon-alpha-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  72. ZHANG RN, Zheng RD, Mi YQ, Zhou D, et al
    APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  73. BRUNS T, Reuken PA, Stengel S, Gerber L, et al
    NOD2 Risk Variants and Pathological Bacterial Translocation in Decompensated Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  74. TAN HK, James PD, Wong F
    Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  75. PECTASIDES E, Miksad R, Pyatibrat S, Srivastava A, et al
    Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  76. JUNG YS, Yun KE, Chang Y, Ryu S, et al
    Risk Factors Such as Male Sex, Smoking, Metabolic Syndrome, Obesity, and Fatty Liver Do Not Justify Screening Colonoscopies Before Age 45.
    Dig Dis Sci. 2016;61:1021-7.
    PubMed     Text format     Abstract available


    March 2016
  77. VUPPALANCHI R, Chalasani N
    Screening Strategies for Nonalcoholic Steatohepatitis in High-Risk Individuals: Trimming Away the Fat.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  78. SARGENTI K, Johansson A, Bertilsson S, Mattsby-Baltzer I, et al
    Dysfunction of Circulating Polymorphonuclear Leukocytes and Monocytes in Ambulatory Cirrhotics Predicts Patient Outcome.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  79. ZHOU H, Li Y, Song X, Zhao Y, et al
    CHST11/13 Regulate the Metastasis and Chemosensitivity of Human Hepatocellular Carcinoma Cells Via Mitogen-Activated Protein Kinase Pathway.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  80. NAGPAL SJ, Kabbany MN, Mohamad B, Lopez R, et al
    Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  81. MOHANTY A, Fortune BE
    Why Pursue a Fourth Year in Advanced/Transplant Hepatology?
    Dig Dis Sci. 2016.
    PubMed     Text format    


  82. ZHU Z, Chen W, Yin X, Lai J, et al
    WAVE3 Induces EMT and Promotes Migration and Invasion in Intrahepatic Cholangiocarcinoma.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  83. TANG S, Zeng W, Qin J, He Q, et al
    Gastric Variceal Bleeding Caused by an Arterioportal Fistula Formation After TIPS and Related Complications.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  84. COREY KE, Rinella ME
    Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  85. COREY KE, Kartoun U, Zheng H, Shaw SY, et al
    Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record.
    Dig Dis Sci. 2016;61:913-9.
    PubMed     Text format     Abstract available


  86. CHO SB, Choi YH, So YH, Ahn DW, et al
    Balloon-Occluded Retrograde Transvenous Obliteration of Jejunal Varices: A Case Report, Therapeutic Approach.
    Dig Dis Sci. 2016;61:948-51.
    PubMed     Text format    


  87. KAWANISHI K, Kato J, Toda N, Yamagami M, et al
    Risk Factors for Aspiration Pneumonia After Endoscopic Hemostasis.
    Dig Dis Sci. 2016;61:835-40.
    PubMed     Text format     Abstract available


  88. PIMENTEL CF, Jiang ZG, Otsubo T, Feldbrugge L, et al
    Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH.
    Dig Dis Sci. 2016;61:905-12.
    PubMed     Text format     Abstract available


    February 2016
  89. DE CARVALHO BT, Coutinho Domingues AL, de Almeida Lopes EP, Brandao SC, et al
    Increased Hepatic Arterial Blood Flow Measured by Hepatic Perfusion Index in Hepatosplenic Schistosomiasis: New Concepts for an Old Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  90. REEVES HL, Zaki MY, Day CP
    Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  91. CARR BI, Guerra V
    Erratum to: Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  92. CHEN L, Guo YZ, Li AD, Ma JJ, et al
    Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  93. SOFTIC S, Cohen DE, Kahn CR
    Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  94. HAAS K, Longacre T, Castillo RO
    Adenovirus Hepatic Abscess: A Novel Source of Fever of Unknown Origin in a Pediatric Liver Transplant Recipient.
    Dig Dis Sci. 2016.
    PubMed     Text format    


    January 2016
  95. COREY KE, Klebanoff MJ, Tramontano AC, Chung RT, et al
    Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  96. PATEL YA, Berg CL, Moylan CA
    Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  97. YARZE N, Yarze JC
    Radiographic and Histologic Findings of a Rare Liver Tumor-Hepatic Epithelioid Hemangioendothelioma.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  98. LANDIS CS, Ghabril M, Rustgi V, Di Bisceglie AM, et al
    Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  99. KAJIHARA J, Tomimaru Y, Eguchi H, Yamada D, et al
    The Clinical Impact of Transcatheter Arterial Chemoembolization (TACE)-Induced c-Met Upregulation on TACE Refractoriness in Hepatocellular Carcinoma.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  100. INTAGLIATA NM, Henry ZH, Maitland H, Shah NL, et al
    Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  101. BORHOFEN SM, Gerner C, Lehmann J, Fimmers R, et al
    The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  102. HA J, Hendrix M, Guyer AG
    Microwave Ablation for the Treatment of Hypersplenism: Short Waves, Low Cost, Big Results.
    Dig Dis Sci. 2016;61:6-7.
    PubMed     Text format    


  103. PETRONE MC, Arcidiacono PG
    EUS-Guided Drainage of Liver Abscesses: Ultra Uncertain or Sound Practice?
    Dig Dis Sci. 2016;61:8-10.
    PubMed     Text format    


  104. LEE T, Yun KE, Chang Y, Ryu S, et al
    Risk of Colorectal Neoplasia According to Fatty Liver Severity and Presence of Gall Bladder Polyps.
    Dig Dis Sci. 2016;61:317-24.
    PubMed     Text format     Abstract available


  105. OGURA T, Masuda D, Saori O, Wataru T, et al
    Clinical Outcome of Endoscopic Ultrasound-Guided Liver Abscess Drainage Using Self-Expandable Covered Metallic Stent (with Video).
    Dig Dis Sci. 2016;61:303-8.
    PubMed     Text format     Abstract available


    December 2015
  106. DYAL HK, Aguilar M, Bartos G, Holt EW, et al
    Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  107. WANG JH, Chen TY, Ou HY, Wang CC, et al
    Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  108. AN J, Zheng L, Xie S, Yin F, et al
    Regulatory Effects and Mechanism of Adenovirus-Mediated PTEN Gene on Hepatic Stellate Cells.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  109. DOU CY, Fan YC, Cao CJ, Yang Y, et al
    Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  110. IBRAHIM SH, Hirsova P, Malhi H, Gores GJ, et al
    Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  111. XIE M, Zhu J, He X, Yang Z, et al
    Liver Metastasis from Colorectal Cancer in the Elderly: Is Surgery Justified?
    Dig Dis Sci. 2015;60:3525-35.
    PubMed     Text format     Abstract available


    November 2015
  112. BLACK SM, Woodley FW, Tumin D, Mumtaz K, et al
    Cystic Fibrosis Associated with Worse Survival After Liver Transplantation.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  113. CARR BI, Guerra V
    Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  114. PARK CH, Han DS, Jeong JY, Eun CS, et al
    Outcomes of Propofol Sedation During Emergency Endoscopy Performed for Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  115. ZHU JZ, Dai YN, Wang YM, Zhou QY, et al
    Prevalence of Nonalcoholic Fatty Liver Disease and Economy.
    Dig Dis Sci. 2015;60:3194-202.
    PubMed     Text format     Abstract available


    October 2015
  116. GRAT M, Wronka KM, Patkowski W, Stypulkowski J, et al
    Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  117. CHUNG H, Chon YE, Kim SU, Lee SK, et al
    Noninvasive Prediction of Erosive Esophagitis Using a Controlled Attenuation Parameter (CAP)-Based Risk Estimation Model.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    September 2015
  118. URRUNAGA NH, Magder LS, Weir MR, Rockey DC, et al
    Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: